Targeted Temperature Management at 33°C for in-hospital cardiac arrest
Official title: Targeted Temperature Management at 33°C Versus Controlled Normothermia for In-hospital Cardiac Arrest
Run by Nantes University Hospital · NCT07086703 · Data updated 2026-11-12
This trial tests whether cooling patients who remain unconscious after a resuscitated in-hospital cardiac arrest to 33°C improves survival with good brain function compared to keeping a normal, controlled temperature.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 788 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 31 sites (Ghent, Belgium and 30 other locations) |
| Status | Recruiting |
| Started | August 13, 2026 |
| Main results expected | August 13, 2029 |
| Study ends | August 13, 2029 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT07086703 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+ years) with unwitnessed IHCA presenting as asystole, who achieve ROSC, remain comatose, and are enrolled within 90 minutes of ROSC with next-of-kin consent.
✕Probably not a fit
Patients without sustained ROSC, with delays beyond 90 minutes, or in whom coma is not present may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized trial compares induced hypothermia at 33°C with controlled normothermia in comatose adults who have had a resuscitated in-hospital cardiac arrest. Participants must have sustained ROSC, evidence of coma, and be enrolled within 90 minutes of ROSC, with next-of-kin consent obtained. The study seeks to determine if 33°C TTM can improve survival with favorable neurological outcome versus normothermia in the IHCA population, where data are limited. Sites include hospitals in Belgium and France, led by Nantes University Hospital with collaboration from Erasme University Hospital. The trial builds on mixed prior evidence from OHCA and IHCA subgroups regarding temperature management effects.
Why it matters
Potential benefit: If successful, patients treated at 33°C could have a higher chance of surviving with good brain function after IHCA.
How similar studies have gone: Prior IHCA subgroups showed signals of benefit with 33°C in small trials, but evidence is not definitive and OHCA data have been mixed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * IHCA (unwitnessed IHCA with initial asystole; these patients may still be eligible if visible or audible signs of life were witnessed within 10 minutes after IHCA (no-flow duration ≤10 minutes, in keeping with the non-inclusion criteria for HYPERION study). * Sustained ROSC (Return Of Spontaneous Circulation) defined as signs of circulation for 20 minutes without chest compressions * At least 1 mg of epinephrine * Coma defined as an inability to obey verbal commands (Glasgow Coma Scale motor response \<6 or Full Outline of UnResponsiveness (FOUR) score motor response \<4) after sustained ROSC * Eligible for intensive care without restrictions or limitations * Inclusion within 90 minutes of ROSC * Age 18 years or older * Next of kin informed about the trial and having consented to participation of the patient in the trial (patients with coma are unable to consent). If no next of kin can be contacted during screening for the study, trial inclusion will be completed as an emergency procedure by the ICU physician, in compliance with Country of inclusion law. * Healthcare costs covered by a healthcare insurance system Exclusion Criteria: * Temperature at admission \<30°C * Obvious or suspected pregnancy * Intracranial bleeding * Dependent on others for activities of daily living before hospitalization * Patient under curators, guardianship or under protection of justice * Correctional facility inmate * Patient who does no speak French
Where it's running
-
Hôpital Universitaire de Gand
Ghent, Belgium, Belgium Recruiting -
Hôpital Universitaire de Bruxelles
Jette, Belgium, Belgium Recruiting -
Clinique Saint-PIerre
Ottignies, Belgium, Belgium Recruiting -
Hôpital Erasme
Brussels, Belgium Recruiting -
CHU Charleroi
Charleroi, Belgium Recruiting -
CH d'Angoulême
Angoulême, France, France Recruiting
Show 25 more locations
-
CH Dubois Brive
Brive-la-Gaillarde, France, France Recruiting -
CHU de Caen
Caen, France, France Recruiting -
Hôpital Simone Veil
Cannes, France, France Recruiting -
CH Public du Cotentin
Cherbourg, France, France Recruiting -
CHU Clermont-Ferrand
Clermont-Ferrand, France, France Recruiting -
CHU Bocage
Dijon, France, France Recruiting -
CHD Vendée
La Roche-sur-Yon, France, France Recruiting -
Hôpital André Mignot
Le Chesnay, France, France Recruiting -
CHRU- Hôpital Roger Salengro
Lille, France, France Recruiting -
CHU Dupuytren
Limoges, France, France Recruiting -
Hôpital Edouard Herriot
Lyon, France, France Recruiting -
APHM - Hôpital Nord
Marseille, France, France Recruiting -
Hôpital Privé Jacques Cartier
Massy, France, France Recruiting -
CHU de Nantes
Nantes, France, France Recruiting -
Hôpital de l'Archet
Nice, France, France Recruiting -
CHR d'Orléans
Orléans, France, France Recruiting -
APHP-Hôpital Saint-Antoine
Paris, France, France Recruiting -
APHP- Hôpital Cochin
Paris, France, France Recruiting -
APHP - Hôpital Ambroise Paré
Paris, France, France Recruiting -
CH de Roanne
Roanne, France, France Recruiting -
CHRU de Strasbourg
Strasbourg, France, France Recruiting -
Hôpital Sainte-Musse
Toulon, France, France Recruiting -
CHRU de Tours
Tours, France, France Recruiting -
CH Brocéliande Atlantique
Vannes, France, France Recruiting -
CHU Les Abymes
Pointe-à-Pitre, La Guadeloupe, Guadeloupe Recruiting
Study contacts
- Study coordinator: Jean-Baptiste LASCARROU, PH
- Email: jeanbaptiste.lascarrou@chu-nantes.fr
- Phone: +33(0)240087386
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Heartsight helps caregivers of kids after cardiac arrest manage uncertainty and fear
This pilot trial tests if the Heartsight information program is acceptable and helpful for caregivers of children who recently had a cardiac arrest.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
Cardiopulmonary resuscitation with balloon occlusion of the descending aorta for hospitalized patients
This trial will test whether adding a balloon occlusion of the descending aorta (REBOA) to standard ACLS helps people having an in-hospital cardiac arrest regain and keep a pulse.
-
Digital serious game to improve critical care nurses' targeted temperature management skills and situational awareness.
We will test whether adding a digital serious game to regular lectures helps adult ICU nurses learn targeted temperature management and improve situational awareness.
-
Plasma proteins, metabolites, and platelet changes in extracorporeal CPR for cardiac arrest patients
This project will test whether patterns in blood proteins, small molecules, and platelet shape changes can help identify which adults with cardiac arrest might benefit from extracorporeal CPR.
-
Goal-directed neuroprotection bundle for adults after cardiac arrest
This trial will test whether a goal-directed bundle of treatments (temperature, breathing gases, position, blood pressure, glucose, sodium and lactate control) helps adults who are unconscious after return of circulation from cardiac arrest recover their brain function better than usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.